Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | YARWYarrow Bioscience, Inc.FY2025 · Dec |
|---|---|
| Revenue | $570.00K |
| Revenue, yoy | +13.8% |
| Net income | $26.48M |
| Net income, yoy | +33.5% |
| Net margin | -4,646.1% |
| Free cash flow | $33.12M |
| FCF margin | -5,811.2% |
| EPS, diluted | $0.62 |
Add another company.